Scholars Central

Conference abstractPublished 5 Jul 2017

3D printing as a practical pharmaceutical manufacturing method

Authors: Clive Roberts

University of Nottingham, UK

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The processes used to produce tablets, the dominant form of medicine taken by patients, have changed relatively little for over a century. While these approaches serve the industry and patients very well, they remain limited and cannot create complex dosage forms or bespoke medications tailored for an individual or sub-population (i.e., personalized medicines). This would be valuable in meeting therapeutic challenges and the need for personalized medicines. 3D printing, off ers a route to address these issues. As an example, I will show a 3DP 5-drug polypill and tablet with novel 3D architecture designed to control drug release. The potential and challenges for using 3DP in the manufacture of medicines will be discussed as well as the considerable challenges that must be met to satisfy scale-up issues and regulatory requirements. I aim to show that 3D printing has already shown the capacity to meet some regulatory requirements and while many challenges remain, this is a technology that could potentially benefit patients and radically alter the way; we make and distribute some medicines.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectPharmaceutical Sciences
  • SubjectEngineering
  • BylineArticles whose byline prints “Clive Roberts”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels